Sectoral Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $742K | Sell |
1,370
-340
| -20% | -$191K | 0.52% | 48 |
|
|
2026
Q1 | $1.15M | Sell |
1,710
-13
| -0.8% | -$6.47K | 0.95% | 27 |
|
|
2025
Q4 | $840K | Buy |
1,723
+958
| +125% | +$446K | 0.67% | 40 |
|
|
2025
Q3 | $321K | Hold |
765
| – | – | 0.2% | 74 |
|
|
2025
Q2 | $220K | Hold |
765
| – | – | 0.15% | 86 |
|
|
2025
Q1 | $236K | Buy |
765
+170
| +29% | +$58.3K | 0.18% | 68 |
|
|
2024
Q4 | $210K | Sell |
595
-465
| -44% | -$171K | 0.14% | 75 |
|
|
2024
Q3 | $380K | Sell |
1,060
-760
| -42% | -$257K | 0.22% | 68 |
|
|
2024
Q2 | $580K | Sell |
1,820
-775
| -30% | -$205K | 0.24% | 62 |
|
|
2024
Q1 | $596K | Sell |
2,595
-220
| -8% | -$49.6K | 0.23% | 62 |
|
|
2023
Q4 | $619K | Buy |
2,815
+200
| +8% | +$46.1K | 0.27% | 69 |
|
|
2023
Q3 | $591K | Buy |
2,615
+368
| +16% | +$84.8K | 0.12% | 104 |
|
|
2023
Q2 | $496K | Buy |
2,247
+432
| +24% | +$95.7K | 0.08% | 107 |
|
|
2023
Q1 | $406K | Hold |
1,815
| – | – | 0.08% | 105 |
|
|
2022
Q4 | $505K | Sell |
1,815
-100
| -5% | -$25.2K | 0.1% | 102 |
|
|
2022
Q3 | $401K | Hold |
1,915
| – | – | 0.08% | 93 |
|
|
2022
Q2 | $451K | Buy |
+1,915
| New | +$389K | 0.09% | 97 |
|
|
2020
Q3 | – | Sell |
-6,600
| Closed | -$799K | – | 174 |
|
|
2020
Q2 | $799K | Buy |
+6,600
| New | +$743K | 0.07% | 111 |
|
|
2016
Q1 | – | Sell |
-195,280
| Closed | -$30.6M | – | 89 |
|
|
2015
Q4 | $30.6M | Buy |
195,280
+19,500
| +11% | +$2.84M | 1.3% | 24 |
|
|
2015
Q3 | $23.1M | Hold |
175,780
| – | – | 1.06% | 25 |
|
|
2015
Q2 | $30.6M | Buy |
175,780
+700
| +0.4% | +$126K | 1.28% | 24 |
|
|
2015
Q1 | $30.2M | Buy |
175,080
+12,200
| +7% | +$1.86M | 1.15% | 31 |
|
|
2014
Q4 | $21.1M | Sell |
162,880
-19,520
| -11% | -$2.52M | 0.95% | 36 |
|
|
2014
Q3 | $23.5M | Hold |
182,400
| – | – | 0.99% | 31 |
|
|
2014
Q2 | $16.1M | Sell |
182,400
-52,000
| -22% | -$5M | 0.68% | 41 |
|
|
2014
Q1 | $22M | Buy |
234,400
+52,400
| +29% | +$5.36M | 0.91% | 37 |
|
|
2013
Q4 | $20.6M | Buy |
+182,000
| New | +$16.4M | 0.89% | 39 |
|
|
2013
Q3 | – | Sell |
-321,032
| Closed | -$21.1M | – | 59 |
|
|
2013
Q2 | $21.1M | Buy |
+321,032
| New | +$20.7M | 0.62% | 38 |
|
Other funds holding UTHR
ACA
JT
Sectoral Asset Management's UTHR Position: Q2 2026 in Review
Sectoral Asset Management reduced its United Therapeutics (UTHR) stake by 20% in Q2 2026, selling an estimated $191K and leaving 1,370 shares worth $742K. The position accounts for 0.52% of the portfolio, ranked #48.
Sectoral Asset Management first reported a position in UTHR in Q2 2013 and has held it in 28 quarters since. The position peaked at $30.6M in Q4 2015. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Sectoral Asset Management held 1,370 shares of United Therapeutics worth $742K as of Q2 2026.
- Sectoral Asset Management sold 340 United Therapeutics shares in Q2 2026, an estimated $191K.
- United Therapeutics made up 0.52% of Sectoral Asset Management's portfolio in Q2 2026, its #48 holding.
- Sectoral Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 28 quarters since.
- Sectoral Asset Management's United Therapeutics position peaked at $30.6M in Q4 2015.
- 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.